NASDAQ:GYRO Gyrodyne - GYRO Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Gyrodyne, LLC Please log in to your account or sign up in order to add this asset to your watchlist. $8.25 0.00 (0.00%) (As of 03/22/2023 12:00 AM ET) Add Compare Share Share Today's Range$8.25▼$8.2550-Day Range$7.80▼$9.1652-Week Range$7.80▼$14.87Volume622 shsAverage Volume529 shsMarket Capitalization$12.21 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media About Gyrodyne (NASDAQ:GYRO) StockGyrodyne LLC engages in the management of a portfolio of medical office and industrial properties. Its properties include Flowerfield, Port Jefferson Professional Park, Courtland Medical Center, and Grove. The company was founded by Peter James Papadakos in 1946 and is headquartered in St. James, NY.Read More Receive GYRO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Gyrodyne and its competitors with MarketBeat's FREE daily newsletter. Email Address GYRO Stock News HeadlinesMarch 19, 2023 | americanbankingnews.comGyrodyne (NASDAQ:GYRO) Stock Price Crosses Below Two Hundred Day Moving Average of $9.11January 30, 2023 | finance.yahoo.comGyrodyne Issues Letter to ShareholdersMarch 23, 2023 | Legacy Research (Affiliate) (Ad)"Prepare for Five Years of Famine"Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecastDecember 26, 2022 | finance.yahoo.comGyrodyne, LLC (GYRO) Stock Historical Prices & Data - Yahoo FinanceAugust 30, 2022 | finance.yahoo.comStar Equity Fund Issues Statement on Gyrodyne’s 2022 AGMAugust 16, 2022 | finance.yahoo.comStar Equity Fund Responds to Proxy Reports for Gyrodyne, LLCAugust 4, 2022 | morningstar.comGyrodyne LLC Stock NewsAugust 3, 2022 | nz.finance.yahoo.comAvelead Expands Agreement with Large Provider Network for Compare SolutionMarch 23, 2023 | Legacy Research (Affiliate) (Ad)"Prepare for Five Years of Famine"Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecastAugust 1, 2022 | finance.yahoo.comStar Equity Fund Intends to Vote WITHHOLD on the Re-Election of Paul Lamb and Richard Smith to the Gyrodyne BoardJuly 31, 2022 | msn.comThings to do with the kids near Reading over the Summer holidays to keep the whole family happyMay 30, 2022 | msn.comVolunteers needed to help the USS Orleck at Jacksonville Naval MuseumApril 1, 2022 | msn.comSmithtown Approves Subdivision Development Of 75-Acre Gyrodyne SiteApril 1, 2022 | finance.yahoo.comGYRODYNE RECEIVES PRELIMINARY SUBDIVISION APPROVAL FOR FLOWERFIELD PROPERTYMarch 25, 2022 | nz.finance.yahoo.comPensa Partners with Blue Yonder to Deliver Continuous Shelf Monitoring and Compliance to CPG Brands and RetailersMarch 23, 2022 | finance.yahoo.comStar Equity Fund Announces Intent to Nominate Director Candidates at Gyrodyne, LLCFebruary 21, 2022 | msn.comBest space board games of 2022January 23, 2022 | nasdaq.comGyrodyne, LLC Common Stock (GYRO)December 1, 2021 | msn.comSt. James To Host Holiday Gift & Toy Drive-ThruSeptember 22, 2021 | msn.comThis heavy-lift drone could quietly carry a sub-hunting torpedoMay 4, 2021 | msn.comProposed Gyrodyne Development Has Residents Divided On Long Island’s North ShoreJune 18, 2020 | www.msn.comFrom Innovative Business Jets to Electric VTOLs: The Best Things in AviationJune 15, 2020 | www.msn.comFrom Innovative Business Jets to Electric VTOLs: The Best Things in Aviation This YearMarch 27, 2020 | www.marketwatch.comGyrodyne LLCMarch 2, 2020 | www.msn.comGyrodyne Development Opponents Hold ProtestNovember 1, 2019 | www.nasdaq.comGyrodyne, LLC Common Stock (GYRO) After-Hours QuotesSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive GYRO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Gyrodyne and its competitors with MarketBeat's FREE daily newsletter. Email Address GYRO Company Calendar Today3/23/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Nonresidential building operators Sub-IndustryDiversified REITs SectorFinance Current SymbolNASDAQ:GYRO CUSIP40382010 CIK1589061 Webwww.gyrodyne.com Phone(631) 584-5400Fax631-584-7075Employees6Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.43 Current Ratio1.77 Quick Ratio1.77 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares1,480,000Free Float1,424,000Market Cap$12.21 million OptionableNot Optionable Beta0.48 Key ExecutivesGary Jay FitlinPresident, CEO, CFO & TreasurerPeter PitsiokosCOO, Secretary, Chief Compliance Officer & EVPDawn IbrahamControllerKey CompetitorsLion GroupNASDAQ:LGHLGeneration Income PropertiesNASDAQ:GIPRPower REITNYSE:PWAmerican Strategic InvestmentNYSE:NYCSHFNASDAQ:SHFSView All CompetitorsInstitutional OwnershipGabelli Funds LLCBought 1,333 shares on 2/13/2023Ownership: 9.827%Towerview LLCBought 14,703 shares on 2/2/2023Ownership: 7.987%View All Institutional Transactions GYRO Stock - Frequently Asked Questions How have GYRO shares performed in 2023? Gyrodyne's stock was trading at $8.10 on January 1st, 2023. Since then, GYRO stock has increased by 1.9% and is now trading at $8.2506. View the best growth stocks for 2023 here. What other stocks do shareholders of Gyrodyne own? Based on aggregate information from My MarketBeat watchlists, some companies that other Gyrodyne investors own include Acasti Pharma (ACST), Amyris (AMRS), Ariad Pharmaceuticals (ARIA), Astrotech (ASTC), Athersys (ATHX), (AVNR) (AVNR), Bank of America (BAC), Citigroup (C), China Auto Logistics (CALI) and (CHTP) (CHTP). What is Gyrodyne's stock symbol? Gyrodyne trades on the NASDAQ under the ticker symbol "GYRO." Who are Gyrodyne's major shareholders? Gyrodyne's stock is owned by many different retail and institutional investors. Top institutional investors include Gabelli Funds LLC (9.83%) and Towerview LLC (7.99%). View institutional ownership trends. How do I buy shares of Gyrodyne? Shares of GYRO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Gyrodyne's stock price today? One share of GYRO stock can currently be purchased for approximately $8.25. How much money does Gyrodyne make? Gyrodyne (NASDAQ:GYRO) has a market capitalization of $12.21 million. How can I contact Gyrodyne? Gyrodyne's mailing address is 1 FLOWERFIELD SUITE 24, ST. JAMES NY, 11780. The official website for the company is www.gyrodyne.com. The real estate investment trust can be reached via phone at (631) 584-5400 or via fax at 631-584-7075. This page (NASDAQ:GYRO) was last updated on 3/23/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.